| 1 | RUBLER S, DLUGASH J, YUCEOGLU Y Z, et al.. New type of cardiomyopathy associated with diabetic glomerulosclerosis[J]. Am. J. Cardiol., 1972,30(6): 595-602. | 
																													
																							| 2 | ALONSO N, MOLINER P, MAURICIO D. Pathogenesis, clinical features and treatment of diabetic cardiomyopathy[J]. Adv. Exp. Med. Biol., 2018,1067: 197-217. | 
																													
																							| 3 | MURTAZA G, VIRK H U H, KHALID M, et al.. Diabetic cardiomyopathy-a comprehensive updated review[J]. Prog. Cardiovasc. Dis., 2019,62(4): 315-326. | 
																													
																							| 4 | RUSSO I, FRANGOGIANNIS N G. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities[J]. J. Mol. Cell. Cardiol., 2016,90: 84-93. | 
																													
																							| 5 | SU C P, WANG Q, LUO H, et al.. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression[J/OL]. Biomed. Pharmacother., 2020,127: 110132[2021-08-29]. . | 
																													
																							| 6 | LIU J C, WANG F, XIE M L, et al.. Osthole inhibits the expressions of collagen I and III through Smad signaling pathway after treatment with TGF-β1 in mouse cardiac fibroblasts[J]. Int. J. Cardiol., 2017,228: 388-393. | 
																													
																							| 7 | FU S, LI Y L, WU Y T, et al.. Icariside II improves myocardial fibrosis in spontaneously hypertensive rats by inhibiting collagen synthesis[J]. J. Pharm. Pharmacol., 2020,72(2): 227-235. | 
																													
																							| 8 | CHEN W, LIN H R, WEI C M, et al.. Echinacoside, a phenylethanoid glycoside from Cistanche deserticola, extends lifespan of Caenorhabditis elegans and protects from Abeta-induced toxicity[J]. Biogerontology, 2018,19(1): 47-65. | 
																													
																							| 9 | LIU J J, YANG L L, DONG Y H, et al.. Echinacoside, an inestimable natural product in treatment of neurological and other disorders[J/OL]. Molecules, 2018,23(5): 1213[2021-08-29]. . | 
																													
																							| 10 | 蔡华, 张领, 李满生, 等. 松果菊苷通过上调miR-34a减轻心肌细胞缺血再灌注损伤[J]. 中国循证心血管医学杂志, 2018,10(6): 739-742, 745. | 
																													
																							| 11 | 杨芳, 吴泽幼, 包思, 等. 松果菊苷通过调节Nrf2表达减轻H2O2致心肌细胞损伤的实验研究[J]. 中国中医急症, 2017,26(12): 2078-2082. | 
																													
																							| 12 | KALAI F, HAN J, KSOURI R, et al.. Oral administration of Nitraria retusa ethanolic extract enhances hepatic lipid metabolism in db/db mice model 'BKS.Cg-Dock7(m)+/+ Lepr(db/)J' through the modulation of lipogenesis-lipolysis balance[J]. Food Chem. Toxicol., 2014,72: 247-256. | 
																													
																							| 13 | LUTZ T A, WOODS S C. Overview of animal models of obesity[J/OL]. Curr. Protoc. Pharmacol., 2012, 5: Unit5.61[2021-08-29]. . | 
																													
																							| 14 | SAEEDI P, PETERSOHN I, SALPEA P, et al.. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition[J/OL]. Diabetes Res. Clin. Pract., 2019,157: 107843[2021-08-29]. . | 
																													
																							| 15 | JIA G H, DEMARCO V G, SOWERS J R. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy[J]. Nat. Rev. Endocrinol., 2016,12(3): 144-153. | 
																													
																							| 16 | JIA G H, WHALEY-CONNELL A, Sowers J R. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease[J]. Diabetologia, 2018,61(1): 21-28. | 
																													
																							| 17 | XIONG W T, GU L, WANG C, et al.. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice[J]. J. Ethnopharmacol., 2013,150(3): 935-945. | 
																													
																							| 18 | NI Y J, DENG J, LIU X, et al.. Echinacoside reverses myocardial remodeling and improves heart function via regulating SIRT1/FOXO3a/MnSOD axis in HF rats induced by isoproterenol[J]. J. Cell. Mol. Med., 2021,25(1): 203-216. | 
																													
																							| 19 | HU H H, CHEN D Q, WANG Y N, et al.. New insights into TGF-β/Smad signaling in tissue fibrosis[J]. Chem. Biol. Interact., 2018,292: 76-83. | 
																													
																							| 20 | YUE Y Y, MENG K, PU Y J, et al.. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy[J]. Diabetes Res. Clin. Pract., 2017,133: 124-130. | 
																													
																							| 21 | ZHAN C Y, TANG J H, ZHOU D X, et al.. Effects of tanshinone IIA on the transforming growth factor beta1/Smad signaling pathway in rat cardiac fibroblasts[J]. Indian J. Pharmacol., 2014,46(6): 633-638. | 
																													
																							| 22 | FERREIRA R R, ABREU R D S, VILAR-PEREIRA G, et al.. TGF-beta inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease[J/OL]. PLoS Negl. Trop. Dis., 2019,13(7): e0007602[2021-08-29]. . |